Raymond James Financial Services Advisors, Inc. Soma Logic, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $69.1 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
SELL
$0.63 - $5.47 $1,260 - $10,940
-2,000 Reduced 8.19%
22,409 $65,000
Q2 2022

Aug 12, 2022
BUY
$4.27 - $8.26 $8,540 - $16,520
2,000 Added 8.92%
24,409 $110,000
Q1 2022

May 11, 2022
BUY
$7.07 - $11.62 $77,692 - $127,692
10,989 Added 96.23%
22,409 $180,000
Q4 2021

Feb 08, 2022
SELL
$10.49 - $14.28 $52,334 - $71,242
-4,989 Reduced 30.4%
11,420 $133,000
Q3 2021

Nov 02, 2021
BUY
$9.94 - $12.77 $163,105 - $209,542
16,409 New
16,409 $203,000

Others Institutions Holding SLGC

# of Institutions
3
Shares Held
7.48M
Call Options Held
0
Put Options Held
0
View Full List

About SomaLogic, Inc.

SLGC Quotes by TradingView
  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email